Trial intelligence / Profile preview

Calcium and Aspirin Supplementation for Prevention of Preeclampsia in High-Risk Pregnancy

TCTR20221001001Phase 3Terminated

Sponsor
N/A
Start
May 2021
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of aspirin in preeclampsia, sponsored by N/A. Started May 2021; status: terminated.

02

Drugs

aspirin
03

Conditions

preeclampsia

Beyond the preview

Go deeper on TCTR20221001001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20221001001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call